Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...

Pfizer (NYSE:PFE) reported positive results from a Phase 3 study of its drug Talzenna in combination with Xtandi in the treatment of certain patients with prostate cancer. The study, called TALAPRO-3, ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

Stockport left the Places for Everyone plan in 2020 and now it looks like another borough in Oldham could follow ...

A council has narrowly voted to withdraw from a controversial housing scheme for more than 10,000 new homes after months of ...

At an extraordinary council session, members last night narrowly voted to pull out of the Greater Manchester spatial framework, reaffirming the weight of opinion from its November council meeting.